Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004178 · ClinicalTrials.gov registry record · Phase 1
Gene Therapy in Treating Patients With Cancer
A Phase 1 study, sponsored by Roger Williams Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00004178 is a Phase 1 study that has completed, run by Roger Williams Medical Center.
The verdict
NCT00004178, a Phase 1 study, has completed, sponsored by Roger Williams Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Inserting a gene that has been created in the laboratory into a person's white blood cells may make the body build an immune response to kill cancer cells. PURPOSE: Phase I trial to study the effectiveness of gene therapy in treating patients who have cancer that has not responded to previous therapy.
Interventions
- BIOLOGICAL therapeutic autologous lymphocytes
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-04 |
| Est. Completion | 2001-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004178
The ClinicalTrials.gov registry entry for NCT00004178 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Roger Williams Medical Center, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which therapeutic autologous lymphocytes is the first listed.
NCT00004178 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004178 about?
NCT00004178 is a clinical study titled "Gene Therapy in Treating Patients With Cancer". RATIONALE: Inserting a gene that has been created in the laboratory into a person's white blood cells may make the body build an immune response to kill cancer cells. PURPOSE: Phase I trial to study the effectiveness of gene therapy in treating patients who have cancer that has not responded to pre...
What is the current status of trial NCT00004178?
This trial is currently completed. It is a Phase 1 study. The study started on 1998-04. Estimated completion is 2001-12.
What interventions are being tested in trial NCT00004178?
The interventions under investigation include: therapeutic autologous lymphocytes (BIOLOGICAL).
Who is sponsoring clinical trial NCT00004178?
This trial is sponsored by Roger Williams Medical Center, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.